23rd May 2022 | Pharma Updates

Sanofi's Dupixent approved for expanded use in US

Sanofi received expanded approval in the United States for its best-selling Dupixent injection, which is used to treat allergic esophagitis. Eosinophilic esophagitis affects more than 160,000 people in the United States (EoE).

Sun Pharma recalls over 10,000 bottles of generic antidepressant medication in US

Following a customer complaint, Sun Pharma is recalling approximately 10,500 bottles of a generic drug intended for the treatment of major depressive disorders in the US market.

Mayo Clinic invests in Karkinos Healthcare for development of innovative cancer care solutions

Mayo Clinic has announced a minority stake in Karkinos Healthcare, subject to certain conditions precedent. As part of this agreement, Mayo Clinic will nominate a member to Karkinos’ Board of Directors.

Amazon and Walmart's Flipkart in talks to buy stake in Metropolis Healthcare

According to people familiar with the matter, Metropolis Healthcare Ltd., a diagnostics chain with operations in India and Africa, is looking to raise more than $300 million and bring on a strategic partner by selling a significant minority stake.

Pfizer to refund $290,000 to customers in four states due to deceptive copay coupons

Pfizer has agreed to refund $290,000 to settle charges of misleading approximately 5,000 people in Colorado, Kansas, Vermont, and Arizona who spent much more than expected when they used coupons supplied by the drug maker.

Janssen introduces icare4u programme for skin, joint, and digestive disorders

Johnson & Johnson’s Janssen Pharmaceutical Companies has announced the launch of icare4u, a comprehensive programme to support the mental and physical health of millions of Indians affected by disorders caused by excessive inflammation.

Piramal Pharma Solutions new API Plant in Canada gone online

Following the completion of its first clinical and commercial scale projects, Piramal Pharma Solutions has started up its active pharmaceutical ingredient (API) production plant.

FDA approved hyaluronic acid filler to smooth wrinkles around the eyes

Juvéderm Volbella XC is a hyaluronic acid filler. For years, it has been injected in smile lines, lips, cheeks, and the jaw line. What’s new is that it’s now FDA approved for under the eyes.